title: Transcatheter aortic valve implantation with a CoreValve bioprosthesis in a 57-year-old man.
abstract: Transcatheter aortic valve implantation (TAVI) is a promising new technology which is typically used to treat elderly patients with severe aortic stenosis who cannot undergo surgical aortic valve replacement due to high risk factors. This procedure may also be a therapeutic option in particular relatively young cases with severe symptomatic aortic stenosis who are unsuitable candidates for surgery. Clinical experience with TAVI in these patients is very limited due to concerns regarding long-term valve durability. Herein, the case is reported of a 57-year-old man with severe aortic stenosis who presented with decompensated heart failure and successfully underwent transfemoral CoreValve implantation. To the best of the present authors' knowledge, this is the youngest reported patient to have received a CoreValve bioprosthesis to date.
authors.affiliation: Ataturk Education and Research Hospital, Cardiology Department, Ankara, Turkey.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Bilge
authors.forename: Hatice
authors.initials: H
authors.lastname: Tolunay
authors.forename: Ayse Saatci
authors.initials: AS
authors.lastname: Yasar
authors.forename: Recai
authors.initials: R
authors.lastname: Alemdar
authors.forename: Sina
authors.initials: S
authors.lastname: Ali
authors.forename: Ozge
authors.initials: O
authors.lastname: Kurmus
mesh_terms: D001021:Aortic Valve; D001024:Aortic Valve Stenosis / Q000150:complications / Q000601:surgery*; D001705:Bioprosthesis; D057510:Endovascular Procedures; D006333:Heart Failure / Q000150:complications; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged